Truist lowered the firm’s price target on Belden (BDC) to $150 from $184 and keeps a Buy rating on the shares. The company delivered good Q1 results and Q2 guidance, but while the RUCKUS acquisition appears to be about 15% accretive to EPS, it raises questions about strategy and capital allocation, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDC:
